hero image
Webinar

MRD testing in AML: Prime time in the clinic?

On-demand
icon_0085_cc_gen_calendar-s
Sep 19, 2024
icon_0310_cc_gen_timeinterval-s
35 minutes

About this webinar

In his presentation, Dr. Heuser discusses the use of measurable residual disease (MRD) in acute myeloid leukemia (AML). He reviews the different methodologies for MRD assessment and also describes the clinical relevance and medical decision-making based on MRD. Finally, he discusses ongoing challenges and future directions with the goal of optimizing MRD usage in leukemia management.

Speakers

Fill out the form to take part in the event